Surface Logix Inc. uses its expertise in biophysical chemistry to create new small molecule drugs that are optimized to meet the challenges of human physiology. The company is advancing multiple internal programs focused primarily on cardiovascular, metabolic, inflammatory and fibrotic diseases.

 
 

What is the Pharmacomer™ Technology Platform

Pharmacomers™ are unique, small molecule groups.

 
 
 
 
 

News and Events